- Home
- BKT vs SGHT Comparison
BKT vs SGHT Comparison
Compare BKT & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKT
- SGHT
- Stock Information
- Founded
- BKT 1988
- SGHT 2011
- Country
- BKT United States
- SGHT United States
- Employees
- BKT N/A
- SGHT N/A
- Industry
- BKT Investment Bankers/Brokers/Service
- SGHT Medical Specialities
- Sector
- BKT Finance
- SGHT Health Care
- Exchange
- BKT Nasdaq
- SGHT Nasdaq
- Market Cap
- BKT 267.4M
- SGHT 304.4M
- IPO Year
- BKT N/A
- SGHT 2021
- Fundamental
- Price
- BKT $11.78
- SGHT $3.80
- Analyst Decision
- BKT
- SGHT Buy
- Analyst Count
- BKT 0
- SGHT 6
- Target Price
- BKT N/A
- SGHT $6.80
- AVG Volume (30 Days)
- BKT 67.9K
- SGHT 262.0K
- Earning Date
- BKT 01-01-0001
- SGHT 11-07-2024
- Dividend Yield
- BKT 8.97%
- SGHT N/A
- EPS Growth
- BKT N/A
- SGHT N/A
- EPS
- BKT N/A
- SGHT N/A
- Revenue
- BKT N/A
- SGHT $79,543,000.00
- Revenue This Year
- BKT N/A
- SGHT $3.06
- Revenue Next Year
- BKT N/A
- SGHT $10.33
- P/E Ratio
- BKT N/A
- SGHT N/A
- Revenue Growth
- BKT N/A
- SGHT N/A
- 52 Week Low
- BKT $10.55
- SGHT $2.04
- 52 Week High
- BKT $12.92
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- BKT 34.90
- SGHT 30.57
- Support Level
- BKT $11.77
- SGHT $4.13
- Resistance Level
- BKT $11.93
- SGHT $5.19
- Average True Range (ATR)
- BKT 0.10
- SGHT 0.32
- MACD
- BKT 0.00
- SGHT -0.09
- Stochastic Oscillator
- BKT 22.54
- SGHT 1.75
About BKT BlackRock Income Trust Inc. (The)
Blackrock Income Trust Inc is a diversified investment fund with an investment objective to manage a portfolio of high-quality securities to achieve both preservations of capital and high monthly income. The trust seeks to achieve its investment objective by investing at least 65% of its assets in mortgage-backed securities. The Fund invests at least 80% of its assets in securities that are (i) issued or guaranteed by the U.S. government or one of its agencies or instrumentalities or (ii) rated at the time of investment either AAA by S&P Global Ratings ("S&P") or Aaa by Moody's Investors Service, Inc ("Moody's"). The Fund may invest directly in such securities or synthetically through the use of derivatives.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.